Home Cart Sign in  
Chemical Structure| 1032508-03-4 Chemical Structure| 1032508-03-4

Structure of PDM11
CAS No.: 1032508-03-4

Chemical Structure| 1032508-03-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PDM 11 is a derivative of the antioxidant trans-resveratrol.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PDM11

CAS No. :1032508-03-4
Formula : C16H15ClO2
M.W : 274.74
SMILES Code : COC1=CC(OC)=CC(/C=C/C2=CC=C(Cl)C=C2)=C1
MDL No. :MFCD08062174

Safety of PDM11

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01147653 Cerebral Palsy ... More >> CP Spastic Cerebral Palsy Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT01147653 - Completed - -
NCT01577316 Pregnancy Inv... More >>estigation or Care in A Nonpregnant Woman Less << Phase 2 Phase 3 Unknown December 2013 Mexico ... More >> National Institute of Public Health Not yet recruiting Cuernavaca, Morelos, Mexico, 62100 Contact: Leticia Ferreyra-Reyes, MD    (52)5554871000 ext 4312    freyes.ld@gmail.com    Sub-Investigator: Renata Baez-Saldaña, MD          Sub-Investigator: Elizabeth Ferreira-Guerrero, MD          Sub-Investigator: Leticia Ferreyra-Reyes, MD          Sub-Investigator: Guadalupe Delgado-Sánchez, MPH          Sub-Investigator: Luis Pablo Cruz-Hervert, MSc          Principal Investigator: Samuel Ponce de Leon-Rosales, MD          Sub-Investigator: Maria Eugenia Jiménez-Corona, DSc Less <<
NCT01380249 Malignant Solid Tumours Phase 1 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT03540823 Systemic Lupus ... More >> Sjogren's Syndrome Less << Phase 4 Recruiting August 23, 2018 Brazil ... More >> Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo Recruiting São Paulo, Brazil, 05403-000 Contact: Eduardo Borba, MD, PhD    551130617490    eduardo.borba@hc.fm.usp.br Less <<
NCT03418519 Hemiplegic Cerebral Palsy With... More >> Spasticity (Diagnosis) Less << Not Applicable Recruiting December 30, 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: JEONG-YI KWON, MD, PHD    +8210-4591-1039    jeongyi.kwon@samsung.com    Principal Investigator: JEONG-YI KWON, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.64mL

0.73mL

0.36mL

18.20mL

3.64mL

1.82mL

36.40mL

7.28mL

3.64mL

References

 

Historical Records

Categories